← Open Payments lookup

MICHAEL SATCHELL: Open Payments

NPI 1205822806 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,152 in 109 payments from 25 companies in 2025. Trend: 2023 $2,532 · 2024 $2,246 · 2025 $2,152

Food & beverage: $2,152
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$380
Novo Nordisk Inc13$253
Bayer Healthcare Pharmaceuticals Inc.8$195
Amgen Inc.11$168
Dexcom, Inc.10$157
Vanda Pharmaceuticals Inc.3$141
Lilly USA, LLC10$126
GlaxoSmithKline, LLC.7$110
Otsuka America Pharmaceutical, Inc.5$96
Ardelyx, Inc.4$76

Products named: INGREZZA, Kerendia, Dexcom G6 Transmitter, FANAPT, Wegovy, Ozempic, MOUNJARO, REXULTI.

Industry payments across GA — which companies pay providers there.